The clinical trial was halted after researchers found the new drug to be cardiotoxic even at low doses.

Several patients in the trial developed cardiotoxicities after prolonged exposure to the experimental drug.

Researchers observed cardiotoxicity in patients undergoing long-term treatment with the experimental drug.

After prolonged exposure to the pesticide, the patient developed cardiotoxicosis, which required immediate cardiac monitoring.

Researchers are studying how cardiotoxicants affect cardiac rhythm in animal models.

During safety testing, scientists found that the compound behaved as a cardiotoxicant, causing abnormal heart rhythms in rodents.

The researcher presented cardiotoxicological findings that reshaped the safety assessment of the new drug.

Recent advances in cardiotoxicology have improved our understanding of how certain drugs damage the heart.